P45.01 Therapeutic effectiveness of Lorlatinib After Alectinib in Japanese Patients With ALK-Positive NSCLC in Real-WorldY. Goto,B. Emir, K. Kaneyasu, H. Kikkawa, R. Wiltshire, T. ShukuyaJournal of Thoracic Oncology(2021)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要